| scholarly article | Q13442814 |
| P2093 | author name string | Birrer MJ | |
| Sabichi AL | |||
| Hendricks DT | |||
| Bober MA | |||
| P2860 | cites work | Five-year administration of fenretinide: pharmacokinetics and effects on plasma retinol concentrations | Q28264846 |
| Suppression of retinoic acid receptor beta in non-small-cell lung cancer in vivo: implications for lung cancer development | Q34426069 | ||
| Nuclear receptors for retinoids: mediators of retinoid effects on normal and malignant cells | Q36435287 | ||
| The transactivating domain of the c-Jun proto-oncoprotein is required for cotransformation of rat embryo cells | Q36744547 | ||
| Involvement of reactive oxygen species in N-(4-hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells | Q41093212 | ||
| Effects of all-trans-retinoic acid and 13-cis-retinoic acid on breast-cancer cell lines: growth inhibition and apoptosis induction. | Q41121298 | ||
| Induction of apoptosis by fenretinide (4HPR) in human ovarian carcinoma cells and its association with retinoic acid receptor expression | Q41229162 | ||
| N-(4-hydroxyphenyl)retinamide (4-HPR)-mediated biological actions involve retinoid receptor-independent pathways in human breast carcinoma | Q41289818 | ||
| Serum vitamin A and subsequent risk of cancer: cancer incidence follow-up of the Finnish Mobile Clinic Health Examination Survey | Q44238640 | ||
| 4-Hydroxyphenyl retinamide is a highly selective activator of retinoid receptors | Q46690362 | ||
| Growth inhibition and induction of apoptosis by fenretinide in small-cell lung cancer cell lines. | Q50756405 | ||
| Cancer statistics, 1997. | Q50980276 | ||
| Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin. | Q53463690 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | tretinoin | Q29417 |
| P304 | page(s) | 597-605 | |
| P577 | publication date | 1998-04-01 | |
| P1433 | published in | Journal of the National Cancer Institute | Q400279 |
| P1476 | title | Retinoic acid receptor beta expression and growth inhibition of gynecologic cancer cells by the synthetic retinoid N-(4-hydroxyphenyl) retinamide | |
| P478 | volume | 90 |
| Q40518875 | A novel retinoid, 4-[3,5-bis (trimethylsilyl) benzamido] benzoic acid (TAC-101), induces apoptosis of human ovarian carcinoma cells and shows potential as a new antitumor agent for clear cell adenocarcinoma |
| Q44251894 | Altered sphingolipid metabolism in N-(4-hydroxyphenyl)-retinamide-resistant A2780 human ovarian carcinoma cells |
| Q38298318 | Antitumor activity of 4-(N-hydroxyphenyl)retinamide conjugated with poly(L-glutamic acid) against ovarian cancer xenografts |
| Q35572432 | Breast cancer prevention trials using retinoids |
| Q34134934 | CL100 expression is down-regulated in advanced epithelial ovarian cancer and its re-expression decreases its malignant potential |
| Q34297476 | Chemoprevention of breast cancer with fenretinide |
| Q34605217 | Classical and novel retinoids: their targets in cancer therapy |
| Q44409661 | Comparison of the mechanism of induction of apoptosis in ovarian carcinoma cells by the conformationally restricted synthetic retinoids CD437 and 4‐HPR |
| Q40679037 | Effect of 4-hydroxyphenylretinamide on human cervical epithelial and cancer cell lines |
| Q35559519 | Elevated retinoic acid receptor beta(4) protein in human breast tumor cells with nuclear and cytoplasmic localization |
| Q40703405 | Elucidation of molecular events mediating induction of apoptosis by synthetic retinoids using a CD437-resistant ovarian carcinoma cell line |
| Q40770152 | Enhanced apoptosis and radiosensitization by combined 13-cis-retinoic acid and interferon-alpha2a; role of RAR-beta gene |
| Q34334842 | Epigenetic downregulation of the retinoic acid receptor-beta2 gene in breast cancer. |
| Q53295021 | Epigenetic regulation of retinoic acid receptor β2 gene in the initiation of breast cancer |
| Q34296248 | Epigenetic therapy with 3-deazaneplanocin A, an inhibitor of the histone methyltransferase EZH2, inhibits growth of non-small cell lung cancer cells. |
| Q38313648 | Evidence that retinoic acid receptor beta induction by retinoids is important for tumor cell growth inhibition |
| Q34107940 | Fenretinide and cancer prevention |
| Q51005071 | Fenretinide prevents obesity in aged female mice in association with increased retinoid and estrogen signaling. |
| Q36635330 | Fenretinide treatment prevents diet-induced obesity in association with major alterations in retinoid homeostatic gene expression in adipose, liver, and hypothalamus. |
| Q35570960 | Fenretinide: a prototype cancer prevention drug |
| Q53414881 | Growth inhibition of cervical cancer cells by the human retinoic acid receptor beta gene. |
| Q36494199 | Growth inhibition of non-small cell lung cancer cells by AP-1 blockade using a cJun dominant-negative mutant. |
| Q38354720 | Identification of cJun-responsive genes in Rat-1a cells using multiple techniques: increased expression of stathmin is necessary for cJun-mediated anchorage-independent growth |
| Q36449459 | Identification of mammalian target of rapamycin as a direct target of fenretinide both in vitro and in vivo |
| Q39360083 | Impact of 4HPR on the expression of E-Cad in human bladder transitional epithelial cancer cells T24. |
| Q39511962 | Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell lines |
| Q33610379 | Inhibitory effects of fenretinide metabolites N-[4-methoxyphenyl]retinamide (MPR) and 4-oxo-N-(4-hydroxyphenyl)retinamide (3-keto-HPR) on fenretinide molecular targets β-carotene oxygenase 1, stearoyl-CoA desaturase 1 and dihydroceramide Δ4-desatura |
| Q40612715 | Involvement of c-Fos in fenretinide-induced apoptosis in human ovarian carcinoma cells |
| Q24805784 | Methylation and silencing of the retinoic acid receptor-beta 2 gene in cervical cancer |
| Q37223430 | Mitogen-activated protein kinase pathway mediates N-(4-hydroxyphenyl)retinamide-induced neuronal differentiation in the ARPE-19 human retinal pigment epithelial cell line |
| Q37196047 | N-(4-Hydroxyphenyl) retinamide potentiated paclitaxel for cell cycle arrest and apoptosis in glioblastoma C6 and RG2 cells |
| Q35013084 | N-(4-Hydroxyphenyl)retinamide induced differentiation with repression of telomerase and cell cycle to increase interferon-gamma sensitivity for apoptosis in human glioblastoma cells |
| Q44757357 | N-(4-hydroxyphenyl) retinamide (4HPR) enhances TRAIL-mediated apoptosis through enhancement of a mitochondrial-dependent amplification loop in ovarian cancer cell lines |
| Q40734731 | N-(4-hydroxyphenyl)retinamide increases ceramide and is cytotoxic to acute lymphoblastic leukemia cell lines, but not to non-malignant lymphocytes. |
| Q35013089 | N-Myc down regulation induced differentiation, early cell cycle exit, and apoptosis in human malignant neuroblastoma cells having wild type or mutant p53. |
| Q35552356 | Ovarian cancer and high-risk women—implications for prevention, screening, and early detection |
| Q33561131 | Randomized double-blind 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in high-risk premenopausal women. |
| Q28260445 | Rb2/p130 and protein phosphatase 2A: key mediators of ovarian carcinoma cell growth suppression by all-trans retinoic acid |
| Q40360219 | Response of human rhabdomyosarcoma cell lines to retinoic acid: relationship with induction of differentiation and retinoic acid sensitivity |
| Q34002981 | Retinoids and ovarian cancer |
| Q34580753 | Selective estrogen receptor modulators (SERMs) and retinoids in breast cancer chemoprevention |
| Q37023890 | Simultaneous blockade of AP-1 and phosphatidylinositol 3-kinase pathway in non-small cell lung cancer cells |
| Q73551924 | Synergistic effects of 8-Cl-cAMP and retinoic acids in the inhibition of growth and induction of apoptosis in ovarian cancer cells: induction of retinoic acid receptor beta |
| Q77340302 | Synergistic effects of retinoic acid and 8-Cl-cAMP on apoptosis require caspase-3 activation in human ovarian cancer cells |
| Q36788454 | Synthetic retinoid fenretinide in breast cancer chemoprevention |
| Q38106981 | The association of retinoic acid receptor beta2(RARβ2) methylation status and prostate cancer risk: a systematic review and meta-analysis |
| Q35053948 | The biology of breast carcinoma |
| Q28188823 | The pro-apoptotic Ras effector Nore1 may serve as a Ras-regulated tumor suppressor in the lung |
| Q37947907 | The science behind vitamins and natural compounds for breast cancer prevention. Getting the most prevention out of it. |
| Q53682893 | Therapeutic effects of the combination of fenretinide and all-trans-retinoic acid and of the two retinoids with cisplatin in a human ovarian carcinoma xenograft and in a cisplatin-resistant sub-line. |
| Q38362494 | Upregulation of GADD153 expression in the apoptotic signaling of N-(4-hydroxyphenyl)retinamide (4HPR). |
| Q74234874 | pRb and Cdk regulation by N-(4-hydroxyphenyl)retinamide |
Search more.